RXO (RXO) Reports In-Line Q4 EPS; offers guidance

Go back to RXO (RXO) Reports In-Line Q4 EPS; offers guidance

RXO, Inc. (RXO) PT Lowered to $24 at Barclays

February 5, 2025 2:17 PM EST

Barclays analyst Brandon Oglenski lowered the price target on RXO, Inc. (NYSE: RXO) to $24.00 (from $30.00) while maintaining a Overweight rating.

The analyst comments "4Q EBITDA slightly ahead of consensus despite elevated costs. RXO reported 4Q24 adjusted EPS of 6c, ahead of... More